Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

CAMBREX CORPORATION (CBM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/13/2018 04/16/2018 04/17/2018 04/18/2018 04/19/2018 Date
54.4(c) 54.95(c) 55.45(c) 55(c) 55.05(c) Last
176 160 128 552 270 930 304 027 119 662 Volume
0.00% +1.01% +0.91% -0.81% +0.09% Change
More quotes
Financials (USD)
Sales 2018 536 M
EBIT 2018 123 M
Net income 2018 92,0 M
Debt 2018 -
Yield 2018 -
Sales 2019 555 M
EBIT 2019 129 M
Net income 2019 98,4 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 19,99
P/E ratio 2019 18,68
Capi. / Sales2018 3,53x
Capi. / Sales2019 3,40x
Capitalization 1 889 M
More Financials
Company
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies to innovator and generic pharmaceutical companies.Its products include generic and branded APIs, controlled... 
Sector
Pharmaceuticals
Calendar
04/26 | 07:00pmShareholder meeting
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
04/19Cambrex Corporation to Provide Additional Information Regarding its Environme..
GL
04/19CAMBREX : invests in new continuous flow technology at its High Point (NC, USA) ..
AQ
04/18CAMBREX : Invests in New Continuous Flow Technology at its High Point, NC Facili..
AQ
04/17CAMBREX : Invests in New Continuous Flow Technology at its High Point, NC Facili..
AQ
04/17CAMBREX : Expanding in High Point With Purchase of Two Buildings, New Hires
AQ
03/27CAMBREX : Recognized At 2018 CMO Leadership Awards
AQ
03/20CAMBREX : FDA approves EU authorities to ensure public safety
AQ
03/13VICORE PHARMA HOL : ing I-Tech strengthens supply chain with strategic acquisiti..
AQ
03/13CAMBREX : I-Tech AB strengthens Selektope® supply chain with strategic acquisiti..
AQ
02/15Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conferen..
GL
More news
Sector news : Pharmaceuticals - NEC
10:20aRUSSIA GIVES GREEN LIGHT TO BAYER'S : Ifax
RE
08:49aShire Attracts Flurry Of Suitors -- WSJ
DJ
08:48aCorrections & Amplifications -- WSJ
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
08:16aSHIRE : Allergan PLC Statement regarding Shire plc
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/19$CBM ALERT: New Cambrex SEC Filing From our Stock News Alerts App 
04/19$CBM Cambrex Corporation to Provide Additional Information Regarding its Envi.. 
04/19Cambrex Corporation to Provide Additional Information Regarding its Environme.. 
04/19Get the latest news and updates for $CBM $BEAT $PAA $NSSC $CRVL automatically.. 
04/19Somewhat Positive Media Coverage Somewhat Unlikely to Impact Cambrex $CBM Sto.. 
More tweets
Qtime:100
News from SeekingAlpha
02/14Premarket analyst action - healthcare 
02/08Cambrex's (CBM) CEO Steven Klosk on Q4 2017 Results - Earnings Call Transcrip.. 
02/08Cambrex beats by $0.15, misses on revenue 
02/07Notable earnings before Thursday?s open 
2017RECRO PHARMACEUTICALS : Prescriptions For Pain Are A Prescription For Gain 
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 60,8 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Tom G. Vadaketh Chief Financial Officer & Vice President
Peter G. Tombros Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION15.52%1 889
JOHNSON & JOHNSON-6.57%342 627
PFIZER0.30%217 064
NOVARTIS-4.37%213 465
ROCHE HOLDING LTD.-12.15%193 887
MERCK AND COMPANY4.71%158 813